(NICE) Nice - Ratings and Ratios
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: US6536561086
CX Platforms, Crime Compliance, Data Intelligence
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 37.7% |
| Value at Risk 5%th | 56.4% |
| Relative Tail Risk | -8.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.70 |
| Alpha | -43.80 |
| CAGR/Max DD | -0.31 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.455 |
| Beta | 0.833 |
| Beta Downside | 0.826 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.92% |
| Mean DD | 27.59% |
| Median DD | 31.82% |
Description: NICE Nice January 06, 2026
NICE Ltd. (NASDAQ:NICE) delivers AI-driven cloud platforms that span customer engagement (CXone Mpower), digital evidence management (Evidencentral), high-end AI workloads (X-Sight), and anti-money-laundering/fraud detection (Xceed). The suite is positioned to capture spending growth in enterprise SaaS, regulatory-driven compliance, and public-sector digital transformation.
Key financial signals (FY 2023): total revenue of $2.1 billion, up 14 % YoY; subscription-based ARR grew 18 % YoY, with a 92 % gross margin on the SaaS component. The company’s North American market now accounts for ~55 % of revenue, reflecting strong adoption of CXone in contact-center modernization.
Sector drivers include accelerating migration to cloud-native CX solutions, heightened AML/fraud scrutiny after recent regulatory reforms, and expanding AI adoption across mid-market firms. NICE’s AI-cloud platform architecture gives it a competitive edge in cross-selling compliance and customer-experience tools to the same enterprise.
For a deeper dive into NICE’s valuation metrics, see the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 561.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 0.93 > 1.0 |
| NWC/Revenue: 13.98% < 20% (prev 35.85%; Δ -21.87% < -1%) |
| CFO/TA 0.15 > 3% & CFO 786.4m > Net Income 561.1m |
| Net Debt (-331.2m) to EBITDA (815.6m): -0.41 < 3 |
| Current Ratio: 1.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.2m) vs 12m ago -2.59% < -2% |
| Gross Margin: 67.05% > 18% (prev 0.67%; Δ 6639 % > 0.5%) |
| Asset Turnover: 55.71% > 50% (prev 50.82%; Δ 4.89% > 0%) |
| Interest Coverage Ratio: 103.1 > 6 (EBITDA TTM 815.6m / Interest Expense TTM 6.11m) |
Altman Z'' 6.18
| A: 0.08 (Total Current Assets 1.38b - Total Current Liabilities 980.2m) / Total Assets 5.15b |
| B: 0.52 (Retained Earnings 2.70b / Total Assets 5.15b) |
| C: 0.12 (EBIT TTM 629.9m / Avg Total Assets 5.17b) |
| D: 2.99 (Book Value of Equity 3.86b / Total Liabilities 1.29b) |
| Altman-Z'' Score: 6.18 = AAA |
Beneish M -2.74
| DSRI: 1.04 (Receivables 714.9m/629.9m, Revenue 2.88b/2.64b) |
| GMI: 0.99 (GM 67.05% / 66.70%) |
| AQI: 1.39 (AQ_t 0.68 / AQ_t-1 0.49) |
| SGI: 1.09 (Revenue 2.88b / 2.64b) |
| TATA: -0.04 (NI 561.1m - CFO 786.4m) / TA 5.15b) |
| Beneish M-Score: -2.74 (Cap -4..+1) = A |
ValueRay F-Score (Strict, 0-100) 83.15
| 1. Piotroski: 9.0pt |
| 2. FCF Yield: 10.63% |
| 3. FCF Margin: 24.70% |
| 4. Debt/Equity: 0.02 |
| 5. Debt/Ebitda: -0.41 |
| 6. ROIC - WACC: 3.55% |
| 7. RoE: 15.29% |
| 8. Revenue Trend: 98.87% |
| 9. EPS Trend: -3.13% |
What is the price of NICE shares?
As of January 26, 2026, the stock is trading at USD 114.44 with a total of 585,199 shares traded.
Over the past week, the price has changed by +2.11%, over one month by +1.55%, over three months by -14.93% and over the past year by -32.91%.
Over the past week, the price has changed by +2.11%, over one month by +1.55%, over three months by -14.93% and over the past year by -32.91%.
Is NICE a buy, sell or hold?
Nice has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy NICE.
- Strong Buy: 10
- Buy: 4
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NICE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 160.7 | 40.4% |
| Analysts Target Price | 160.7 | 40.4% |
| ValueRay Target Price | 94.2 | -17.7% |
NICE Fundamental Data Overview January 25, 2026
P/E Trailing = 13.0045
P/E Forward = 9.7943
P/S = 2.4529
P/B = 1.8302
P/EG = 0.9504
Revenue TTM = 2.88b USD
EBIT TTM = 629.9m USD
EBITDA TTM = 815.6m USD
Long Term Debt = 86.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 12.8m USD (from shortTermDebt, last quarter)
Debt = 86.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -331.2m USD (from netDebt column, last quarter)
Enterprise Value = 6.70b USD (7.07b + Debt 86.9m - CCE 455.9m)
Interest Coverage Ratio = 103.1 (Ebit TTM 629.9m / Interest Expense TTM 6.11m)
EV/FCF = 9.41x (Enterprise Value 6.70b / FCF TTM 711.6m)
FCF Yield = 10.63% (FCF TTM 711.6m / Enterprise Value 6.70b)
FCF Margin = 24.70% (FCF TTM 711.6m / Revenue TTM 2.88b)
Net Margin = 19.48% (Net Income TTM 561.1m / Revenue TTM 2.88b)
Gross Margin = 67.05% ((Revenue TTM 2.88b - Cost of Revenue TTM 949.0m) / Revenue TTM)
Gross Margin QoQ = 66.81% (prev 66.75%)
Tobins Q-Ratio = 1.30 (Enterprise Value 6.70b / Total Assets 5.15b)
Interest Expense / Debt = 7.04% (Interest Expense 6.11m / Debt 86.9m)
Taxrate = 20.37% (37.1m / 181.9m)
NOPAT = 501.6m (EBIT 629.9m * (1 - 20.37%))
Current Ratio = 1.41 (Total Current Assets 1.38b / Total Current Liabilities 980.2m)
Debt / Equity = 0.02 (Debt 86.9m / totalStockholderEquity, last quarter 3.86b)
Debt / EBITDA = -0.41 (Net Debt -331.2m / EBITDA 815.6m)
Debt / FCF = -0.47 (Net Debt -331.2m / FCF TTM 711.6m)
Total Stockholder Equity = 3.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.85% (Net Income 561.1m / Total Assets 5.15b)
RoE = 15.29% (Net Income TTM 561.1m / Total Stockholder Equity 3.67b)
RoCE = 16.76% (EBIT 629.9m / Capital Employed (Equity 3.67b + L.T.Debt 86.9m))
RoIC = 12.49% (NOPAT 501.6m / Invested Capital 4.01b)
WACC = 8.94% (E(7.07b)/V(7.15b) * Re(8.98%) + D(86.9m)/V(7.15b) * Rd(7.04%) * (1-Tc(0.20)))
Discount Rate = 8.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 78.27% ; FCFF base≈694.3m ; Y1≈856.4m ; Y5≈1.46b
Fair Price DCF = 340.6 (EV 20.70b - Net Debt -331.2m = Equity 21.03b / Shares 61.7m; r=8.94% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -3.13 | EPS CAGR: -43.96% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.87 | Revenue CAGR: 9.56% | SUE: 0.76 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.62 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=14
EPS next Year (2026-12-31): EPS=11.12 | Chg30d=-0.009 | Revisions Net=-1 | Growth EPS=-9.4% | Growth Revenue=+8.2%
P/E Forward = 9.7943
P/S = 2.4529
P/B = 1.8302
P/EG = 0.9504
Revenue TTM = 2.88b USD
EBIT TTM = 629.9m USD
EBITDA TTM = 815.6m USD
Long Term Debt = 86.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 12.8m USD (from shortTermDebt, last quarter)
Debt = 86.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -331.2m USD (from netDebt column, last quarter)
Enterprise Value = 6.70b USD (7.07b + Debt 86.9m - CCE 455.9m)
Interest Coverage Ratio = 103.1 (Ebit TTM 629.9m / Interest Expense TTM 6.11m)
EV/FCF = 9.41x (Enterprise Value 6.70b / FCF TTM 711.6m)
FCF Yield = 10.63% (FCF TTM 711.6m / Enterprise Value 6.70b)
FCF Margin = 24.70% (FCF TTM 711.6m / Revenue TTM 2.88b)
Net Margin = 19.48% (Net Income TTM 561.1m / Revenue TTM 2.88b)
Gross Margin = 67.05% ((Revenue TTM 2.88b - Cost of Revenue TTM 949.0m) / Revenue TTM)
Gross Margin QoQ = 66.81% (prev 66.75%)
Tobins Q-Ratio = 1.30 (Enterprise Value 6.70b / Total Assets 5.15b)
Interest Expense / Debt = 7.04% (Interest Expense 6.11m / Debt 86.9m)
Taxrate = 20.37% (37.1m / 181.9m)
NOPAT = 501.6m (EBIT 629.9m * (1 - 20.37%))
Current Ratio = 1.41 (Total Current Assets 1.38b / Total Current Liabilities 980.2m)
Debt / Equity = 0.02 (Debt 86.9m / totalStockholderEquity, last quarter 3.86b)
Debt / EBITDA = -0.41 (Net Debt -331.2m / EBITDA 815.6m)
Debt / FCF = -0.47 (Net Debt -331.2m / FCF TTM 711.6m)
Total Stockholder Equity = 3.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.85% (Net Income 561.1m / Total Assets 5.15b)
RoE = 15.29% (Net Income TTM 561.1m / Total Stockholder Equity 3.67b)
RoCE = 16.76% (EBIT 629.9m / Capital Employed (Equity 3.67b + L.T.Debt 86.9m))
RoIC = 12.49% (NOPAT 501.6m / Invested Capital 4.01b)
WACC = 8.94% (E(7.07b)/V(7.15b) * Re(8.98%) + D(86.9m)/V(7.15b) * Rd(7.04%) * (1-Tc(0.20)))
Discount Rate = 8.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 78.27% ; FCFF base≈694.3m ; Y1≈856.4m ; Y5≈1.46b
Fair Price DCF = 340.6 (EV 20.70b - Net Debt -331.2m = Equity 21.03b / Shares 61.7m; r=8.94% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -3.13 | EPS CAGR: -43.96% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.87 | Revenue CAGR: 9.56% | SUE: 0.76 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.62 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=14
EPS next Year (2026-12-31): EPS=11.12 | Chg30d=-0.009 | Revisions Net=-1 | Growth EPS=-9.4% | Growth Revenue=+8.2%
Additional Sources for NICE Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle